Total Raised

$3.68M

Investors Count

12

Funding, Valuation & Revenue

10 Fundings

OCON Therapeutics has raised $3.68M over 10 rounds.

OCON Therapeutics's latest funding round was a Series A for on June 24, 2024.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/24/2024

Series A

RH Capital, Astia Angels, Exerte Partners, Features Capital, and Undisclosed Angel Investors

$XXM

0

FY undefined

2

6/24/2024

Grant - II

Israel Innovation Authority

$XXM

0

FY undefined

1

1/1/2022

Incubator/Accelerator

$XXM

0

FY undefined

1

12/21/2020

Seed VC - II

$XXM

0

FY undefined

10

12/21/2020

Grant

$XXM

0

FY undefined

10

Date

6/24/2024

6/24/2024

1/1/2022

12/21/2020

12/21/2020

Round

Series A

Grant - II

Incubator/Accelerator

Seed VC - II

Grant

Amount

Investors

RH Capital, Astia Angels, Exerte Partners, Features Capital, and Undisclosed Angel Investors

Israel Innovation Authority

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

2

1

1

10

10

Start free trial
New call-to-action

OCON Therapeutics Investors

12 Investors

OCON Therapeutics has 12 investors. Astia Angels invested in OCON Therapeutics's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/21/2020

6/24/2024

2
Seed VC - II, Series A (2024)

Angel Investor (Group)

California

12/21/2020

6/24/2024

Israel Innovation Authority
2
Grant, Grant - II (2024)

Government

Israel

6/24/2024

6/24/2024

1
Series A

Venture Capital

New Hampshire

00/00/0000

00/00/0000

Exerte Partners

Subscribe to see more

Other

Cyprus

00/00/0000

00/00/0000

RH Capital

Subscribe to see more

Venture Capital

California

First funding

12/21/2020

12/21/2020

6/24/2024

00/00/0000

00/00/0000

Last Funding

6/24/2024

6/24/2024

6/24/2024

00/00/0000

00/00/0000

Investor

Israel Innovation Authority

Exerte Partners

RH Capital

Rounds

2
Seed VC - II, Series A (2024)
2
Grant, Grant - II (2024)
1
Series A

Subscribe to see more

Subscribe to see more

Board Seats

Type

Angel Investor (Group)

Government

Venture Capital

Other

Venture Capital

Location

California

Israel

New Hampshire

Cyprus

California

New call-to-action

Compare OCON Therapeutics to Competitors

Aeroflow Urology Logo
Aeroflow Urology

Aeroflow Urology is a durable medical equipment supplier focused on continence care supplies within the healthcare sector. The company provides incontinence products for various ages, body types, and sizes, and serves individuals in need of continence care across the United States. It is based in Asheville, North Carolina.

ConTIPI Medical Logo
ConTIPI Medical

ConTIPI Medical provides non-surgical and disposable vaginal solutions for women with pelvic floor disorders within the medical device industry. The company offers products intended for insertion and removal by the user, addressing conditions like stress urinary incontinence and pelvic organ prolapse. These devices are for home use, enabling women to manage their conditions privately and conveniently. ConTIPI Medical was formerly known as Contipi. It was founded in 2002 and is based in Caesarea, Israel. ConTIPI Medical operates as a subsidiary of Kimberly-Clark.

A
Athena Feminine Technologies

Athena Feminine Technologies focuses on providing healthcare solutions in the feminine health sector. The company offers the Athena Pelvic Muscle Trainer, a wireless device that employs Pelvic Floor Electrical Stimulation (PFES) to assist women in strengthening their pelvic muscles, addressing issues like urinary incontinence. The device is intended for athletic women, new mothers, and post-menopausal seniors, allowing users to perform Kegel exercises at home. It is based in San Mateo, California.

I
InControl Medical

InControl Medical is a company that focuses on the healthcare sector, specifically in the treatment of bladder and bowel leakage. The company offers FDA cleared, in-home medical devices that aim to treat various types of incontinence through muscle stimulation, biofeedback, and guided exercise programs. These devices are designed to strengthen the muscles of the pelvic floor, helping to eliminate urinary and fecal incontinence. It was founded in 2010 and is based in Brookfield, Wisconsin.

E
Elidah

Elidah focuses on women's health and offers devices that use neuromuscular stimulation to treat stress and urge urinary incontinence. The products are designed to be worn externally and provide a treatment option that can be used at home. It was founded in 2015 and is based in Monroe, Connecticut.

Perifit Logo
Perifit

Perifit specializes in health-tech products designed for women, focusing on the health technology sector. The company offers Kegel exercisers that integrate with video games for pelvic floor strengthening and a hands-free breast pump, both aimed at postpartum recovery and general women's health. These products are designed to be used in conjunction with a mobile app for ease of use and enhanced functionality. It was founded in 2017 and is based in Paris, France.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.